SynthesisBMJ (Clinical research ed.)2016

Dipeptidyl peptidase-4 inhibitors and risk of heart failure in type 2 diabetes: systematic review and meta-analysis of randomised and observational studies.

Ling Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.